C2P Capital Advisory Group, LLC d.b.a. Prosperity Capital Advisors
Position in GILD — Gilead Sciences, Inc.
CIK 1965756
Westlake, OH
Position in GILD
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$271,125
-$28,938 QoQ
Shares Held
2,146
-0.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
#1,728
of 2,266 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026C2P Capital Advisory Group, LLC d.b.a. Prosperity Capital Advisors holds $11,231,670 across 7 Drug Manufacturers - General names. GILD ranks #7 (2.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
20,281 | $5,103,510 | |
| 2 | JNJ |
Johnson & Johnson
|
7,826 | $1,987,569 | |
| 3 | LLY |
ELI LILLY & Co
|
1,374 | $1,648,016 | |
| 4 | MRK |
Merck & Co., Inc.
|
6,782 | $871,487 | |
| 5 | PFE |
Pfizer Inc
|
32,587 | $784,694 | |
| 6 | AMGN |
Amgen Inc
|
1,561 | $565,269 | |
| 7 | GILD |
Gilead Sciences, Inc.
This page
|
2,146 | $271,125 |
All Filings in GILD
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $271,125 | 2,146 | Shares | Sole | 2026-07-20 | |
| 2026-03-31 | $300,063 | 2,153 | Shares | Sole | 2026-04-09 | |
| 2025-12-31 | $224,736 | 1,831 | Shares | Sole | 2026-01-20 | |
| No filing history on record for this holder in this stock. | ||||||